Cilo Cybin Holdings Valuation

Is CCC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CCC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CCC (ZAR2.01) is trading below our estimate of fair value (ZAR2.11)

Significantly Below Fair Value: CCC is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CCC?

Key metric: As CCC is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for CCC. This is calculated by dividing CCC's market cap by their current book value.
What is CCC's PB Ratio?
PB Ratio	2.7x
Book	R52.08m
Market Cap	R142.04m

CCC key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	n/a
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does CCC's PB Ratio compare to its peers?

The above table shows the PB ratio for CCC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	1.1x
ASC Ascendis Health	0.7x	n/a	R450.5m
AIP Adcock Ingram Holdings	1.8x	n/a	R9.9b
APN Aspen Pharmacare Holdings	0.9x	22.4%	R76.1b
TLPH Talphera	0.9x	31.3%	US$11.4m
CCC Cilo Cybin Holdings	2.7x	n/a	R142.0m

Price-To-Book vs Peers: CCC is expensive based on its Price-To-Book Ratio (2.7x) compared to the peer average (1.1x).

Price to Book Ratio vs Industry

How does CCC's PB Ratio compare vs other companies in the African Pharmaceuticals Industry?

0 Companies	Price / Book	Estimated Growth	Market Cap

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: CCC is expensive based on its Price-To-Book Ratio (2.7x) compared to the African Pharmaceuticals industry average (1.8x).

Price to Book Ratio vs Fair Ratio

What is CCC's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CCC PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	2.7x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate CCC's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.